Indonesia is satisfied with the effectiveness of Chinese vaccine

Beijing (AP) — Indonesia said Monday that it was pleased with the effectiveness of the Sinovac Coronavirus vaccine in use after China’s top disease control authorities confirmed that the current vaccine has poor protection against the virus. Stated.

Siti Nadia Tarmizi, a spokesman for the Indonesian COVID-19 vaccine program, said the World Health Organization has found that Chinese vaccines meet the requirements with more than 50% effectiveness. She said clinical trials of the Sinovac vaccine in Indonesia showed a 65% efficacy.

“That means we’re talking about the fact that our body’s ability to form antibodies is still very good,” she said.

Mr. Gao, director of the Chinese Center for Disease Control and Prevention, said at a meeting on Saturday that the effectiveness of the existing COVID-19 vaccine is low, and the combination vaccine is one of the strategies being considered to increase its effectiveness. Said. These comments seemed contrary to China’s official story of trying to promote China’s vaccines and sometimes damaging the credibility of Western nations.

China distributes hundreds of millions of domestically produced vaccines abroad and relies on them for its own mass vaccination campaigns.

Tarmizi said Indonesia will wait to confirm the results of clinical trials before considering vaccine combinations.

“We will wait for clinical trials to confirm that ideas and innovations have better efficacy, immunogenicity, and efficacy levels compared to their current state,” she said. ..

Experts say that mixed vaccines or continuous vaccination may increase efficacy. British researchers are studying possible combinations of Pfizer and AstraZeneca vaccines.

China is currently using five vaccines in a mass vaccination campaign, three inactivated virus vaccines from Sinovac and Sinopharm, a one-shot vaccine from CanSino, and the last vaccine from Gao’s team affiliated with Anhui Zhifei Longcom. It has been.

Vaccine efficacy ranges from just over 50% to 79%, based on what the company says.

Both Pfizer and Modana vaccines, used primarily in developed countries, have been shown in studies to be approximately 95% effective in protecting against COVID-19.

According to Gao, as of April 2, about 34 million people in China have been vaccinated twice and about 65 million have been vaccinated once.

Globally, public health experts say that a vaccine that is 50% effective would be useful, and many governments as developed countries around the world collect shots from Pfizer and Moderna. Is enthusiastic about the use of vaccines in China.

China’s Foreign Minister Wang Yi said on Monday that Beijing will continue to provide the COVID-19 vaccine that developing countries are in urgent need of.

“China has provided important support for pandemic countermeasures to more than 160 countries and international organizations,” Wang said at a conference to promote the image of Wuhan’s central city, where the virus was first detected in late 2019. Said for.